other_material
confidence high
sentiment neutral
materiality 0.20
Outlook Therapeutics annual meeting elects three Class I directors, ratifies KPMG, approves say-on-pay
Outlook Therapeutics, Inc.
- Yezan Haddadin, Faisal G. Sukhtian, Kurt J. Hilzinger elected as Class I directors with votes for >12M each.
- KPMG LLP ratified as independent auditor for FY2026 with 35.6M votes for, 0.8M against, 0.9M abstain.
- Non-binding advisory vote on exec compensation approved: 13.9M for, 1.5M against, 0.4M abstain.
- Approximately 50.7% of outstanding shares (37.3M of 73.5M) represented at meeting.